EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes

Masataka Kusunoki, Fumiya Hisano, Shin-ichi Matsuda, Kohei Kunitsu, Daijiro Miyanaga, Masaaki Kusunoki, Kazuhiko Tsutsumi, Tetsuro Miyata

Journal of Endocrinology and Metabolism · 2026-06 · 16 (3) · 142-147

DOI: 10.14740/jem1637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology and Metabolism, 2026-06. Verfasst von Masataka Kusunoki und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kusunoki, M., Hisano, F., Matsuda, S., Kunitsu, K., Miyanaga, D., Kusunoki, M., Tsutsumi, K., & Miyata, T. (2026). The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes. Journal of Endocrinology and Metabolism, 16(3), 142-147. https://doi.org/10.14740/jem1637

Vancouver

Kusunoki M, Hisano F, Matsuda S, Kunitsu K, Miyanaga D, Kusunoki M, et al. The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes. Journal of Endocrinology and Metabolism. 2026;16(3):142-147. doi:10.14740/jem1637

BibTeX
@article{Kusunoki2026,
  author = {Kusunoki, Masataka and Hisano, Fumiya and Matsuda, Shin-ichi and Kunitsu, Kohei and Miyanaga, Daijiro and Kusunoki, Masaaki and Tsutsumi, Kazuhiko and Miyata, Tetsuro},
  title = {The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes},
  journal = {Journal of Endocrinology and Metabolism},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {142--147},
  doi = {10.14740/jem1637}
}
Kostenlos starten →